A continuum of innovation brings patients a new treatment for Ewing sarcoma

While surgery and radiation therapy are generally successful in treating Ewing sarcoma, difficult-to-treat and relapsed cases still experience poor outcomes. A new combo therapy from St. Jude which targets the DNA damage response pathway of tumor cells softens the tumor for radiation therapy, offering a potentially more successful and prolonged treatment.

Read more: https://www.stjude.org/research/progress/2025/continuum-of-innovation-brings-patients-a-new-treatment-for-ewing-sarcoma.html